Cancer control potential of marine natural product scaffolds through inhibition of tumor cell migration and invasion

被引：18
|
作者：
Mudit, Mudit [1 ]
El Sayed, Khalid A. [2 ]
机构：
[1] DYouville Coll Sch Pharm, Dept Pharmaceut Social & Adm Sci, Buffalo, NY 14201 USA
[2] Univ Louisiana Monroe, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA
来源：
DRUG DISCOVERY TODAY | 2016年 / 21卷 / 11期
关键词：
XESTOSPONGIA-EXIGUA KIRKPATRICK; RICH CYCLIC OCTAPEPTIDE; MOTUPORAMINES A-C; BREAST-CANCER; DRUG DISCOVERY; IN-VITRO; PHENYLMETHYLENE HYDANTOINS; MESENCHYMAL TRANSITION; BIOLOGICAL-PROPERTIES; ANTICANCER AGENTS;
D O I：
10.1016/j.drudis.2016.06.032
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The marine environment is a reliable source for the discovery of novel treatment options for numerous diseases. Past research efforts toward the discovery of marine-derived anticancer agents have resulted in several commercially available marine-based drugs. The pharmaceutical value of anticancer drugs from marine natural products (MNPs) ranges from US$563 billion to US$5.69 trillion. In this review, we highlight several marine-derived entities with the potential for cancer control and prevention through the inhibition of crucial tumor cell motility and/or migration steps involved in subsequent cancer metastases. This report also covers the major hurdles typically faced by the MNPs research scientific community.
引用
收藏
页码：1745 / 1760
页数：16
相关论文
共 50 条
  • [1] Inhibition of Tumor Cell Migration and Invasion Through Knockdown of Rac1 Expression in Medulloblastoma Cells
    Baodong Chen
    Yongzhong Gao
    Taipeng Jiang
    Jianjun Ding
    Yanjun Zeng
    Ruxiang Xu
    Xiaodan Jiang
    Cellular and Molecular Neurobiology, 2011, 31 : 251 - 257
  • [2] Inhibition of Tumor Cell Migration and Invasion Through Knockdown of Rac1 Expression in Medulloblastoma Cells
    Chen, Baodong
    Gao, Yongzhong
    Jiang, Taipeng
    Ding, Jianjun
    Zeng, Yanjun
    Xu, Ruxiang
    Jiang, Xiaodan
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2011, 31 (02) : 251 - 257
  • [3] Sulforaphene Interferes with Human Breast Cancer Cell Migration and Invasion through Inhibition of Hedgehog Signaling
    Bao, Cheng
    Kim, Min Chae
    Chen, Jing
    Song, Jieun
    Ko, Hyuk Wan
    Lee, Hong Jin
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2016, 64 (27) : 5515 - 5524
  • [4] Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity
    Jung, Jinkyu
    Celiku, Orieta
    Rubin, Benjamin I.
    Gilbert, Mark R.
    CANCERS, 2024, 16 (11)
  • [5] Inhibition of autophagy mitigates cell migration and invasion in thyroid cancer
    Holm, Tammy M.
    Bian, Z. Christine
    Manupati, Kanakaraju
    Guan, Jun-Lin
    SURGERY, 2022, 171 (01) : 235 - 244
  • [6] Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics
    Mir, Reyaz Hassan
    Mir, Prince Ahad
    Uppal, Jasreen
    Chawla, Apporva
    Patel, Mitesh
    Bardakci, Fevzi
    Adnan, Mohd
    Mohi-ud-din, Roohi
    METABOLITES, 2023, 13 (04)
  • [7] Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer
    Turner, David P.
    Moussa, Omar
    Sauane, Moira
    Fisher, Paul B.
    Watson, Dennis K.
    CANCER RESEARCH, 2007, 67 (04) : 1618 - 1625
  • [8] Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII
    Giuntini, Gaia
    Monaci, Sara
    Cau, Ylenia
    Mori, Mattia
    Naldini, Antonella
    Carraro, Fabio
    CANCERS, 2020, 12 (10) : 1 - 15
  • [9] Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C
    Ullsten, Sara
    Hansen, Kine Ostnes
    Petit, Guillaume Axel
    Hansen, Espen Holst
    Andersen, Jeanette Hammer
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Inhibition of autophagy mitigates cell migration and invasion in thyroid cancer Discussion
    Cohen, Mark
    Holm, Tammy
    Velazquez-Fernandez, David
    Pablo Pantoja, Juan
    Fahey, Thomas J., III
    SURGERY, 2022, 171 (01) : 244 - 244
12345